Adjusting antimüllerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome.

Fertility and Sterility
Glenn E PalomakiAjay Kumar

Abstract

To examine whether accounting for a woman's age and body mass index (BMI) would improve the ability of antimüllerian hormone (AMH) to distinguish between women with (cases) and without (controls) polycystic ovarian syndrome (PCOS). An opportunistic case-control dataset of reproductive age women having evaluations for PCOS as defined by National Institutes of Health criteria. Two medical centers in the United States enrolled women. Serum samples were analyzed for relevant analytes. Women were between 18 and 39 years of age when samples and clinical information were collected. Residual samples had been stored for 2-17 years. AMH was measured via immunoassay. None; this was an observational study. Detection and false-positive rates for PCOS were computed for AMH results expressed as multiples of the median (MoM) both before and after adjustment for the woman's age and BMI. Using unadjusted AMH MoM results, 168 cases (78%) cases were at or beyond the 90th centile of controls (2.47 MoM). After accounting for each woman's age and BMI, 188 (87%) of those women were beyond the 90th centile of controls (2.20 MoM), a significant increase (P = .015). The adjusted AMH MoM levels fitted logarithmic normal distributions well (mean, standard ...Continue Reading

References

Feb 1, 1987·American Journal of Obstetrics and Gynecology·G E Palomaki, J E Haddow
Aug 1, 1981·American Journal of Obstetrics and Gynecology·R HatchD Tredway
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·R S LegroA Dunaif
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·A VermeulenJ M Kaufman
Dec 23, 2003·Human Reproduction·UNKNOWN Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group
Dec 22, 2005·The Journal of Clinical Endocrinology and Metabolism·P PignyD Dewailly
Aug 28, 2007·Lancet·Robert J NormanTheresa E Hickey
Sep 24, 2010·Molecular Endocrinology·Nathalie di ClementeRichard L Cate
Oct 16, 2012·Endocrine Reviews·Evanthia Diamanti-Kandarakis, Andrea Dunaif
Nov 3, 2012·The Journal of Clinical Endocrinology and Metabolism·Priscilla MutharasanMargrit Urbanek
Apr 29, 2014·Human Reproduction·Roy Homburg, Giselle Crawford
Jul 22, 2015·Journal of Assisted Reproduction and Genetics·Vicky MoyErkan Buyuk
Aug 12, 2016·Nature Reviews. Disease Primers·Ricardo AzzizBulent O Yildiz
Jul 20, 2018·Clinical Endocrinology·Helena J TeedeUNKNOWN International PCOS Network
Nov 7, 2018·Fertility and Sterility·Chelsea AndersonHazel B Nichols
Nov 23, 2018·International Journal of Environmental Research and Public Health·Wendy M WolfMelissa D Olfert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.